Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conversion to Extended-release MeltDose® Tacrolimus After Kidney Transplantation - Impact on Glucose Metabolism and Lipid Profile

NCT05396898 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05396898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05396898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conversion to Extended-release MeltDose® Tacrolimus After Kidney Transplantation - Impact on Glucose Metabolism and Lipid Profile
Lead sponsor
University Hospital Tuebingen
Phase
Phase 4
Overall status
Completed
Start date
December 16, 2020
Completion date
December 30, 2023
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttransplant diabetes mellitus